This current protocol employs fluorescent reporters, in vivo labeling, and intravital imaging techniques to enable monitoring of the dynamic process of neutrophil priming in living animals.
Neutrophils are the most abundant leukocytes in human blood circulation and are quickly recruited to inflammatory sites. Priming is a critical event that enhances the phagocytic functionality of neutrophils. Although extensive studies have unveiled the existence and importance of neutrophil priming during infection and injury, means of visualizing this process in vivo have been unavailable. The protocol provided enables monitoring of the dynamic process of neutrophil priming in living animals by combining three methodologies: 1) DsRed reporter signal — used as a measure of priming 2) in vivo neutrophil labeling — achieved by injection of fluorescence-conjugated anti-lymphocyte antigen 6G (Ly6G) monoclonal antibody (mAb) and 3) intravital confocal imaging. Several critical steps are involved in this protocol: oxazolone-induced mouse ear skin inflammation, appropriate sedation of animals, repeated injections of anti-Ly6G mAb, and prevention of focus drift during imaging. Although a few limitations have been observed, such as the limit of continuous imaging time (~ 8 hr) in one mouse and the leakage of fluorescein isothiocyanate-dextran from blood vessels in the inflammatory state, this protocol provides a fundamental framework for intravital imaging of primed neutrophil behavior and function, which can easily be expanded to examination of other immune cells in mouse inflammation models.
Neutrophils are the most abundant and short-lived leukocytes in circulation. They are rapidly recruited to the sites of infection or injury, where they serve as professional phagocytes through release of reactive oxygen and nitrogen intermediates along with granules containing antimicrobial peptides and proteases1. During their recruitment, neutrophils are "primed" by various agents including microbial products, chemoattractants, and inflammatory cytokines, resulting in markedly enhanced phagocyte functionality upon arrival at a site of inflammation2. The mechanisms of neutrophil priming have been extensively studied in vitro3,4; however, dynamic monitoring of the process in vivo has not been possible to date.
Recently, intravital imaging has become an important technique for visualizing and quantifying the cellular dynamics of biological processes in living organisms. Intravital imaging can be performed via conventional one-photon excitation microscopy (e.g., confocal) or multiphoton microscopy approaches5. Over time, substantial improvements have been achieved in this technique enabling increased image resolution, improved imaging depth, decreased tissue photodamage, and enhanced image stabilization6,7. Given its unique ability to enable dynamic visualization of cellular migration and interaction over time, intravital microscopy has been extensively applied to diverse areas of study in immunology8. Intravital imaging enables immunologists to better understand and contextualize immune responses at both the cellular and molecular level in living animal models.
Recent advances in transgenic as well as knock-in reporter mice have provided useful tools for monitoring the dynamic behaviors of neutrophils in living animals. Lysozyme M promoter-driven enhanced green fluorescent protein knock-in mice have been broadly used to characterize motility of neutrophils, monocytes, and macrophages during various inflammatory processes including extravasation, bacterial infection, and sterile inflammation9-15. Further, transgenic mice expressing a cytoplasmic fluorescence resonance energy transfer biosensor have been employed in studying the activities of neutrophil extracellular-regulated mitogen kinase and protein kinase A within inflamed intestine16. A murine model with high specificity for fluorescence expression in neutrophils is the Catchup knock-in mouse, which produces Cre recombinase as well as the fluorescent protein tdTomato, which itself is coupled to expression of lymphocyte antigen 6G (Ly6G)17. Visualization of Ly6G-deficient neutrophils via this model has demonstrated that these cells exert normal functionality in a variety of sterile or infectious in vivo inflammatory contexts. Transgenic mice expressing the DsRed fluorescent protein gene under the control of the mouse interleuikin-1β (IL-1β) promoter (pIL1-DsRed) have been utilized to visualize the motile behaviors of IL-1β producing cells — believed to include neutrophils, inflammatory monocytes, and activated macrophages — emerging in inflamed skin18.
In vivo labeling can serve as an alternative approach for tracing the cellular and molecular behaviors of neutrophils in inflamed tissues. After intravenous injection of low doses of fluorescently labeled anti-Gr-1 monoclonal antibody (mAb), the recruitment cascade of Gr-1+ neutrophils has been visualized in mouse skin lesions infected with Staphylococcus aureus19. In vivo administration of conjugates containing streptavidin-conjugated 705 nm quantum dots and biotinylated anti-Ly6G mAb specifically label circulating neutrophils20. Moreover, endocytosis of such conjugates into neutrophil vesicles allows tracking of high-speed vesicle transport in neutrophils migrating into the interstitium. In vivo labeling with fluorescence-conjugated antibodies against P-selectin glycoprotein ligand-1 (PSGL-1), L-selectin (CD62L), integrin αM (CD11b) and chemokine (C-X-C motif) receptor 2 (CXCR2) in a TNFα-induced inflammatory model has elucidated the regulatory mechanisms at play during early inflammation21. Polarized neutrophils protrude PSGL-1-enriched uropods to interact with CD62L present on activated platelets, resulting in the redistribution of CD11b and CXCR2, receptors that drive neutrophil migration and initiate the inflammation.
IL-1β is one of the signature genes that is elevated in primed neutrophils22. In pIL1-DsRed reporter mice, DsRed fluorescence signals (i.e., activation of IL-1β promoter) positively correlate with IL-1β mRNA expression and IL-1β protein production.18 To monitor the process of neutrophil priming, an intravital microscopy method was developed involving induction of skin inflammation with oxazolone (OX) in the pIL1-DsRed mouse model following in vivo labeling of neutrophils with fluorescence-conjugated anti-Ly6G mAb. Via this model, it is possible to study the behavior and function of primed neutrophils in animal models of various diseases and disorders.
All animal experiments are performed in accordance with the National Institutes of Health guidelines and approved by the Institutional Animal Care and Use Committee of the University of Toledo.
1. Phenotyping of pIL1-DsRed Mice
NOTE: Offspring are generated by breeding heterozygous pIL1-DsRed mice with wild-type (WT) C57BL6 mice. Three to four week old pups are considered ready for phenotyping. Submandibular bleeding of mice follows an established protocol with minor modifications23.
2. Induction of Skin Inflammation in pIL1-DsRed Mice
3. Labeling of Neutrophils in pIL1-DsRed Mice
NOTE: In vivo labeling of neutrophils by low dose fluorescence-conjugated neutrophil-specific mAb follows a recently developed protocol19. Retro-orbital injections are performed according to an established protocol with a few modifications24.
4. Intravital Imaging of Neutrophil Priming in pIL-1-DsRed Mice
Screening of pIL1-DsRed mice is performed based on the phenotypic DsRed fluorescence signal produced by their peripheral blood leukocytes using flow cytometry. LPS stimulation is known to induce IL-1β production in myeloid cells including neutrophils, monocytes, and dendritic cells26-28. Thus, isolated leukocytes are incubated with LPS for 4 hr prior to flow cytometry analysis. Next, gating is set for circulating myeloid cells based on cell size (FSC) and internal complexity (SSC) (Figure 1A)29, and DsRed signal is measured in this gated population. Circulating myeloid cells from WT mice minimally express DsRed, while the same cells from pIL1-DsRed mice express distinguishable DsRed signals (Figure 1B). The pIL1-DsRed mice identified by this phenotyping method are used for subsequent experiments. It should be noted that the complete phenotyping process takes only a few hours — much shorter than the traditional genotyping methods including tissue harvest, enzymatic digestion, DNA isolation, PCR and electrophoresis.
IL-1β promoter activation has recently been identified as a marker of neutrophil priming22. Thus, the dynamic process of neutrophil priming can be visualized and assessed in living animals using pIL1-DsRed mice. To induce skin inflammation, the skin sensitizer OX is topically applied on the right ear of pIL1-DsRed mice and vehicle alone is applied on the left ear of the same animal. To label neutrophils in living animals, a recently developed protocol is performed by administering a small amount of fluorescently labeled anti-Ly6G mAb immediately before and 8 hr after OX application. To locate blood vessels, FITC-dextran is injected immediately prior to imaging.
At 24 hr after OX application, a large number of DsRed+/Ly6G+ cells are found in the extravascular space (Figure 2A) and represent primed neutrophils. A small number of DsRed/Ly6G+ cells are also found, which most likely represent resting neutrophils. Moreover, a small population of DsRed+/Ly6G– cells are observed, which may comprise inflammatory monocytes and activated macrophages. In a 40 min time-lapse video, Ly6G+ neutrophils emerging within an inflammatory skin lesion exhibit typical amoeba-like crawling movement (Supplemental Movie 1). Cell migratory paths are tracked to compare motile behaviors of the DsRed+/Ly6G+ and DsRed–/Ly6G+ neutrophil populations (Figure 2B). The track plot analyses reveal that both neutrophil populations display "random" migration once the extracellular space has been entered (Figure 2C). Interestingly, DsRed+/Ly6G+ neutrophils exhibit a significantly higher velocity compared with their DsRed–/Ly6G+ counterparts (Figure 2D). This suggests an association between neutrophil priming and accelerated motility in inflammatory lesions.
To monitor the timing of neutrophil priming, a series of time-lapse videos were recorded starting at different times following OX treatment (Supplemental Movies 2 – 4). DsRed–/Ly6G+ cells, the resting neutrophils, become detectable in the extravascular space as early as 8 – 12 hr after OX application and their numbers remain relatively low thereafter (Figure 2E, Supplemental Movies 3, 4). On the contrary, the number of DsRed+/Ly6G+ cells, the primed neutrophils, increase progressively at later time points, beginning at 14 – 16 hr after OX application. Some DsRed–/Ly6G+ cells gradually acquire DsRed signals after recruitment to the extravascular space during this period (Figure 2F, Supplemental Movie 5). At 16 – 20 hr, a majority of the extravascular Ly6G+ neutrophils are considered as "primed" based on their DsRed expression. These observations reveal the magnitude, tempo, and location of neutrophil priming occurring at inflammatory lesions in living animals.
Figure 1: Phenotyping of pIL1-DsRed Mice. (A) Flow cytometry analyses demonstrate a population of circulating myeloid cells (G1) based on FSC and SSC parameters. (B) Histograms at the FL2 channel show the percentage of DsRed+ cells within G1 gate of the cells from pIL-DsRed mice (red) or from WT mice (blue). Data are representative of at least three independent experiments. Please click here to view a larger version of this figure.
Figure 2: Visualization of Motile Activities of DsRed+/Ly6G+ Neutrophils in Inflammatory Skin Lesions. (A) Static confocal microscopy images recorded 24 hr after OX treatment show three leukocyte populations in the extravascular space, i.e., DsRed+/Ly6G+ cells (asterisks), DsRed–/Ly6G+ cells (triangles), and DsRed+/Ly6G– cells (arrows). Bar = 20 µm. DsRed+/Ly6G+ cells (red) and DsRed–/Ly6G+ cells (blue) are compared for migratory paths (B), track plots (C), and velocity (D) from a 40 min time-lapse movie recorded by confocal microscopy starting 24 hr after OX application (Supplemental Movie 1). (D) Bars indicate mean velocity values. *** P <0.001. (E) The numbers of DsRed+/Ly6G+ cells and DsRed–/Ly6G+ cells are counted from a series of time-lapse movies recorded at different time-points after OX application (Supplemental Movies 2 through 4). The data shown are the cell numbers/mm2 (means ± SD) calculated from three consecutive images. (F) Static images are created from a time-lapse movie recorded from 11 to 14.5 hr after OX painting (Supplemental Movie 5). The arrow indicates a Ly6G+ cell that acquires DsRed expression in the extravascular space during the observation period. Bar = 50 µm. Images are reproduced from reference 22 with permission (Copyright 2015. The American Association of Immunologists, Inc.). Please click here to view a larger version of this figure.
Supplemental Movie 1: Motile Behavior of DsRed+ Neutrophils in Inflammatory Skin Lesions (at 24 hr after OX painting). Confocal microscopy images show the motility of DsRed+/Ly6G+ cells (pink) and DsRed–/Ly6G+ cells (blue) in the extravascular space. Blood vessels are seen in green. Bar = 20 µm. The video is reproduced from reference 22 with permission (Copyright 2015. The American Association of Immunologists, Inc.). Please click here to view this video.
Supplemental Movie 2: Motile Behavior of DsRed+ Neutrophils in Inflammatory Skin Lesions (at 4 hr after OX painting). Confocal microscopy images show DsRed+/Ly6G+ cells (pink) and DsRed–/Ly6G+ cells (blue) in the extravascular space. Blood vessels are seen in green. Autofluorescence is present and associated with hair follicles. Bar = 100 µm. The video is reproduced from reference 22 with permission (Copyright 2015. The American Association of Immunologists, Inc.). Please click here to view this video.
Supplemental Movie 3: Motile Behavior of DsRed+ Neutrophils in Inflammatory Skin Lesions (at 8 hr after OX painting). Confocal microscopy images show DsRed+/Ly6G+ cells (pink) and DsRed–/Ly6G+ cells (blue) in the extravascular space. Blood vessels are seen in green. Autofluorescence is present and associated with hair follicles. Bar = 100 µm. The video is reproduced from reference 22 with permission (Copyright 2015. The American Association of Immunologists, Inc.). Please click here to view this video.
Supplemental Movie 4: Motile Behavior of DsRed+ Neutrophils in Inflammatory Skin Lesions (at 11 – 19 hr after OX painting). Confocal microscopy images show DsRed+/Ly6G+ cells (pink) and DsRed–/Ly6G+ cells (blue) in the extravascular space. Blood vessels are seen in green. Autofluorescence is present and associated with hair follicles. Bar = 100 µm. The video is reproduced from reference 22 with permission (Copyright 2015. The American Association of Immunologists, Inc.). Please click here to view this video.
Supplemental Movie 5: Acquisition of DsRed Signals by Ly6G+ Neutrophils. From the time-lapse movie shown in supplemental Video 4, this higher magnification video shows the process in which a Ly6G+ cell (indicated with an arrow) acquires DsRed expression in the extravascular space during the observation period (11-14.5 hr after OX painting). Bar = 50 µm. The video is reproduced from reference 22 with permission (Copyright 2015. The American Association of Immunologists, Inc.). Please click here to view this video.
The aim of this study is to develop a technology for monitoring the process of neutrophil priming in living animals, which has not yet been fulfilled by the currently available techniques. To achieve this goal, three established methodologies are performed: 1) induction of skin inflammation in IL-1β promoter-driven DsRed reporter mice as a measure of priming, 2) in vivo labeling of neutrophils with low doses of fluorescence-conjugated anti-Ly6G mAb, and 3) intravital confocal microscopy imaging. The combination of these three methods enables visualization of the motile activities of primed neutrophils (DsRed+/Ly6G+) in inflammatory skin lesions. The migration direction and velocity of the primed neutrophils is further quantified via migratory path tracking. By recording a series of time-lapse videos, the real-time kinetics of primed neutrophil emergence is monitored at inflammatory site and acquisition of DsRed expression by individual neutrophils is also observed in the extravascular space. Thus, the dynamic process of neutrophil priming has been successfully visualized in living animals for the first time using the technology presented here.
This technology is employed in several critical steps. First, skin tissues are the most convenient body parts for intravital imaging. Topical application of OX on the mouse ear allows direct visualization of immune cell behaviors in inflamed skin under confocal microscopy. Second, the mouse must be sedated constantly during imaging which necessitates repeat injections of anesthetic. However, over-sedation may cause mouse die during imaging. To avoid overdose, low doses of anesthetic (a half or a third of the full dose) are recommended for long-term imaging. Third, fluorescence-conjugated neutrophil-specific mAb must be injected intermittently due to the short lifespan of murine neutrophils (half-life of 8-10 hr30). Last, focus drift is a major issue during time-lapse imaging, which could be caused by multiple factors including temperature variations, mouse body movement, ear swelling over time, and vibrations arising from operation of the instrument31. Several methods have been developed to prevent drifting, such as administration of a constant dose of sedation during imaging, fixing the mouse ear in place by taping a glass slide over it on the stage, installing an environmental chamber to provide oxygen and warmth to the sedated organism as well as by manually re-focusing the scope when necessary32,33.
It is equally important to state the limitations of this protocol. First, a slow mouse recovery (12 – 16 hr) after an imaging period 8 hr in length is observed due to continuous sedation, indicating that this protocol may not be suitable for such lengthy experiments. An alternative approach is to use several mice in sequence over the imaging period rather than using only one. Second, a gradual leak of circulating FITC-dextran is observed during imaging over time, which is likely caused by increased permeability of skin blood vessels in the inflammatory state34. Thus, visualization of blood vessels is markedly compromised given reduced fluorescence in circulation at later stages of imaging. Alternatively, one may use fluorescently conjugated lectins such as isolectin B4 to mark blood vessels as these adhere to vascular endothelial cells35.
In addition to visualization of the process of neutrophil priming in skin inflammatory lesions, the technology described here can also be applied in many other experimental settings. In combination with recently developed imaging windows, intravital microscopy delineating the behaviors of primed neutrophils could be assessed in deep tissues and organs including brain, mammary glands, lungs, and abdominal organs36-39. Moreover, visualization of priming/activation of other cell types such as monocytes and macrophages could be achieved using pIL1-DsRed mice along with in vivo labeling via fluorescence-conjugated mAb specific to the cell type of interest. Taken together, not only does this technology provide a fundamental framework for intravital imaging of the priming process of neutrophils in living animals, but it also unveils new approaches for studying the behavior and function of other immune cells in various inflammatory states unfolding in different tissues.
The authors have nothing to disclose.
The authors have no acknowledgements.
Heparin sodium | APP Pharmaceuticals | NDC 63323-540-31 | |
ACK lysing buffer | Lonza | 10-548E | |
Fetal bovine serum | Sigma-Aldrich | F0926 | |
Lipopolysaccharides | Sigma-Aldrich | L4391 | |
Ketamine hydrochloride | Hospira | NDC 0409-2051-05 | |
Xylazine | LLOYD Laboratory | NADA #139-236 | |
Acepromazine | Boehringer Ingelheim | ANADA 200-361 | |
Hair-removal cream | Church & Dwight | ||
Acetone | Fisher Scientific | A16P4 | |
Oxazolone | Sigma-Aldrich | E0753 | |
Alexa Fluor 647 anti-mouse Ly6G antibody | BioLegend | 127610 | |
U-100 insulin syringe with 28 G needle | BD | 329461 | |
FITC-CM-Dextran, 150 Kda | Sigma-Aldrich | 74817 | |
Butterfly infusion set (27 G needle) | BD | 387312 | |
FACSCalibur cytometer | BD | ||
CellQuest Pro software | BD | ||
Confocal microscope | Olympus | FV1000 | |
Metamorph Software | Universal Imaging |